GEODE CAPITAL MANAGEMENT, LLC
Position in ARMP — Armata Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in ARMP
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,753,163
+$580,121 QoQ
Shares Held
270,550
+136.2% QoQ
Ownership
0.728%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 53 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARMP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,870,628,057 across 520 Biotechnology names. ARMP ranks #294 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ARMP
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,753,163 | 270,550 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,173,042 | 114,555 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $690,095 | 109,888 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $311,546 | 104,546 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $198,637 | 104,546 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $154,521 | 105,837 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $197,558 | 106,789 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $253,746 | 107,066 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $292,844 | 106,489 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $417,531 | 99,888 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $327,282 | 101,013 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $303,039 | 101,013 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $25,607 | 22,463 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $37,513 | 22,463 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $27,854 | 22,463 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $95,068 | 22,528 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $87,633 | 22,528 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $108,660 | 22,221 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $55,830 | 10,188 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $36,880 | 10,188 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $40,446 | 10,188 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $48,698 | 10,188 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||